There will be several events at the upcoming 2010 ISEH meeting in Melbourne specifically for young investigators. These events provide a forum for young investigators to meet established professors from around the world that are experts in many aspects of stem cell biology and hematopoiesis, discuss career paths with senior scientists from academia and industry, and socialize with other junior investigators who will be their colleagues for years to come. To participate in these young investigator events, you can add the young investigators package for only AUS$75 to your meeting registration. For this amount you can attend one Meet-the-Professors breakfast, the young investigators night out, and the career panel discussion. For more details on each event see the descriptions below.
1. Meet-the-Professors Breakfast
Thursday September 16 from 7-8am or Friday September 17 from 7-8am
Here is your opportunity to meet and talk with preeminent researchers in stem cell and hematopoietic research in a small informal setting. At each breakfast, tables will consist of one professor and up to 10 junior investigators. Below is the list of professors to choose from and the day they will be available. With your registration for the young investigators events you can select one professor to meet on either the Thursday or Friday breakfast sessions.
1. David Scadden (USA) - BOOKED OUT
Dr. Scadden received his medical training at Case Western Reserve University prior to doing a post-doctoral fellowship at Harvard Medical School (USA). He is now the director for the Center for Regenerative Medicine at Massachusetts General Hospital, and in collaboration with Dr. Douglas Melton serves as co-chair for the Department of Stem Cell and Regenerative Biology at Harvard University and co-director of the Harvard Stem Cell Institute. His work emphasizes targeting the stem cell niche to attain novel therapies for blood diseases. Most recently his laboratory has utilized live-animal imaging to track the behavior of individual hematopoietic stem/progenitor cells in real time. He is the 2012 President-Elect for ISEH.
2. Catherine Verfaille (Belgium)
Dr. Verfaillie’s research focuses on hematopoiesis and pluripotent stem cell biology. She has published more than 150 primary peer-reviewed articles on these topics and has received numerous awards in recognition of her work. She is currently the director of the Stem Cell Institute of Catholic University in Leuven, Belgium. She has formerly served as President of ISEH.
3. Gerald de Haan (Holland)
Dr. de Haan did his PhD at the University of Cologne (Germany) and the University of Groningen (the Netherlands) under the supervision of Professor Markus Loeffler and Dr. William Nijhof. Currently he is the head of the Department of Stem Cell Biology at the University Medical Center Groningen. His laboratory uses a variety of genetic, genomics, and bioinformatics approaches to examine the control of HSC homeostasis. Particularly, he has focused on uncovering the complex traits that underlie HSC aging using murine Quantitative Trait Locus Mapping.
4. Toshio Suda (Japan)
Dr. Suda is the current President of ISEH and is a Professor in the Department of Cell Differentiation at Keio University School of Medicine (Tokyo). Dr. Suda has made significant contributions to our understanding of the role of the bone marrow niche in regulating the functionality of hematopoietic stem cells.
5. John Yu (Taiwan)
Dr. Yu received his training in medicine and science from National Taiwan University (Taiwan), the University of Chicago, and Harvard University (USA). He is currently the Stem Cell Program Director at the Genomic Research Institute, Academia Sinica in Taiwan. The major foci of the Stem Cell Program are differentiation, reprogramming and the derivation of human and primate pluripotent cells.
6. Gou Young Koh (Korea)
Dr. Koh received his MD/PhD from Chonbuk National University Medical School (Korea). He currently runs the National Research Laboratory of Vascular Biology and Stem Cells at the Korean Advanced Institute of Science and Technology (KAIST). His research centers on imaging the remodeling of blood and lymphatic vessels and stem cells, and engineering therapeutically useful molecules such as COMP-Ang1 and DAAP to treat vascular disease.
7. Domminique Bonnet (UK) -
Dr. Bonnet did her scientific training at the University Paris VII (France) and the Hospital for Sick Children, Toronto (Canada) with Drs. Martine Guigon, Albert Najman, and John Dick. She is currently a Senior Group Leader and Head of the Hematopoietic Stem Cell Laboratory at the Cancer Research UK London Research Institute. Her research interests are the cellular and molecular mechanisms that control human hematopoietic stem cells and the changes to this program that can result in leukemia.
8. Juliet Barker (USA)
Dr. Barker received her training in medicine from the Royal Adelaide Hospital, Westmead Hospital (Australia) and the University of Minnesota (USA). She is currently an Attending Physician in the Allogeneic Bone Marrow Transplant Program, Department of Medicine at Memorial Sloan-Kettering Cancer Center where she directs their Cord Blood Transplant Program. She has a particular interest in optimal unit selection, the use of double unit cord blood grafts and cord blood transplantation after reduced intensity and non-myeloablative conditioning.
9. Keith Humphries (Canada) BOOKED OUT
Dr. Humphries is Professor of Medicine at the University of British Columbia and Distinguished Scientist in the Terry Fox laboratory of the BC Cancer Agency. His research focuses on the molecular/genetic regulation of normal and leukemic stem cells. Dr. Humphries has been a leader in these fields for many years making important contributions to the role of homeobox genes in leukemia and novel methods for stimulating HSC expansion. Very recent work has also taken his group into the emerging area of micro RNAs and epigenetic regulators such as MLL5 and ASXL1. Dr. Humphries has been a long time active member of ISEH, serving as president and is now incoming Editor of the societies journal, Experimental Hematology.
10. Ihor Lemischka (USA) BOOKED OUT
Dr. Lemischka received his scientific training at MIT and the Whitehead Institute for Biomedical Research (USA) with Drs. Phil Sharp and Richard Mulligan. He is currently the Director of the Black Family Stem Cell Institute at the Mount Sinai School of Medicine and Professor in the Departments of Developmental and Regenerative Biology and Gene and Cell Medicine. His primary research interest is in the regulation of stem cell states, how they change during differentiation, and the molecular mechanisms underlying these alterations. He has pioneered the use of many large-scale genomics and proteomics for the study of stem cell states.
11. Andrew Elefanty (Aus)
Dr. Elefanty completed his scientific training in leukemogenesis at the Walter and Eliza Hall Institute of Medical Research (Australia) and the National Institute for Medical Research (England) under the mentorships of Drs. Suzanne Cory, Frank Grosveld, and Glenn Begley. In collaboration with Dr. Stanley, he currently heads the Embryonic Stem Cell Differentiation Laboratory at Monash University (Australia). His research focuses on the directed differentiation of human embryonic stem cells and their culture in animal product free media.
12. Nick Nicola (Aus)
Dr. Nicola is a Professor at the Walter and Eliza Hall Institute of Medical Research. He has been a leader in the field of cytokines for over 30 years, cloning and characterizing several important cytokines such as G-CSF, GM-CSF, and LIF, and identifying the SOCS family of cytokine signaling inhibitors. In particular, his laboratory investigates the role of cytokines and cytokine signaling pathways in the development and maintenance of leukemic cell populations, and the utility of cytokines in cancer therapies.
13. George Lacaud (UK)
Dr. Lacaud obtained his PhD from the University Louis Pasteur of Strasbourg (France) and did his postdoctoral fellowship at the National Jewish Medical Center (USA) with Dr. Gordon Keller. He is currently a junior group leader at the Paterson Institute for Cancer Research (UK) and the head of the Stem Cell Biology Group. His group studies early hematopoietic development and leukemia, including the roles of Runx1 and MOZ in these processes.
14. Paul Kincade (USA)
Dr. Kincade is head of the Immunobiology and Cancer Research Program at the Oklahoma Medical Research Foundation. He examines the developmental relationships between HSC and progenitors of B, T, NK, and plasmacytoid dendritic cells. He is particularly interested in how lineage fate decisions are influenced by acute and chronic immune responses.
2. Young Investigator’s Night Out
Thursday September 16 from 7pm at Langerfield Bar and Beer Garden at the Crown Casino Hotel.
This social event is a great way to meet other young investigators from around the world doing stem cell and hematopoiesis research. Come mingle with your future colleagues over some snacks and a few drinks.
3. Career Panel Discussion: Academia, Industry, and Translational Research
Saturday September 18 from 7-8am
This event focuses on helping inform young scientists as you choose a path for your future scientific endeavors. We have compiled a panel of investigators from academia and industry whose work encompasses basic and translational science. They will offer their stories on the path that they took and answer questions you may have on how to follow in their footsteps.
Merv Yoder (Chair)
Dr. Yoder is a neonatalogist who trained at the Indiana School of Medicine, the University of Pennsylvania and the Children’s Hospital of Philadelphia (USA). He is currently the director of the Herman B. Wells Center for Pediatric Research in the School of Medicine at Indiana University. Dr. Yoder has made significant contributions to our understanding of developmental hematopoiesis and continues to pursue research in this arena with a focus on the contribution of the endothelium of the yolk sac to the development of the blood system. He has recently pursued development of methods to examine the clonal proliferative potential of endothelial cells and their role in blood vessel repair and regeneration. He served formerly as the president of ISEH.
C. Glenn Begley
Dr. Begley received his medical and scientific training at Royal Melbourne Hospital and the Walter and Eliza Hall Institute of Medical Research (Australia), and performed his postdoctoral work at the National Cancer Institute (USA). In 1990, he then returned to the Royal Melbourne Hospital and Walter and Eliza Hall Institute as a professor where his group studied the transcription factor SCL, and the role of hematopoietic growth factors both pre-clinically and in the clinic. In 2002, Dr. Begley joined Amgen and is currently Vice President, Global Hematology and Oncology Research.
Dr. Crooks received her medical training from the University of Western Australia, Princess Margaret Hospital for Children, and Children’s Hospital Los Angeles. She is currently a professor in the Departments of Pathology and Laboratory Medicine and Pediatrics, and is also a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA. Her research interests focus on identification and functional characterization of human hematopoietic stem and progenitor cell populations, hematopoiesis from human pluripotent stem cells and thymic regeneration after transplantation.